期刊文献+

磷脂酰肌醇蛋白多糖3基因沉默联合三氟拉嗪对肝癌细胞增殖和凋亡的影响

Effects of phosphatidylinositol proteoglycan 3 gene silencing combined with trifluoperazine on proliferation and apoptosis of liver cancer cells
原文传递
导出
摘要 目的研究磷脂酰肌醇蛋白多糖3(GPC3)基因沉默联合三氟拉嗪(TFP)对肝癌细胞增殖和凋亡的影响。方法将肝癌细胞HepG2分为对照组、TFP组、TFP+si-NC组和TFP+si-GPC3组。TFP组用20μmol·L^(-1)TFP处理,TFP+si-NC组转染si-NC且用20μmol·L^(-1)TFP处理,TFP+si-GPC3组转染si-GPC3且用20μmol·L^(-1)TFP处理,对照组不转染且不用TFP处理。用细胞计数试剂盒-8(CCK-8)法检测不同浓度TFP对HepG2细胞生长的抑制作用,计算药物的半抑制浓度(IC50)并选择最适药物浓度。用流式细胞仪检测各组细胞凋亡情况;用蛋白质印迹(Western blot)法检测细胞凋亡相关蛋白裂解的胱天蛋白酶3(Cl-caspase-3)、B细胞淋巴瘤-2相关X蛋白(Bax)的表达;用实时荧光定量聚合酶链反应(qRT-PCR)和Western blot检测GPC3基因和蛋白的表达;用CCK-8法检测各组细胞活力。结果对照组、TFP组、TFP+si-NC组和TFP+si-GPC3组的GPC3蛋白表达水平分别为0.90±0.06,0.57±0.07,0.57±0.08和0.27±0.06,细胞活力分别为(100.00±0.00)%,(54.47±5.95)%,(52.24±4.10)%和(22.70±2.86)%,细胞凋亡率分别为(2.84±0.61)%,(22.37±1.36)%,(20.82±0.81)%和(31.72±1.92)%,Cl-caspase-3蛋白表达水平分别为0.37±0.05,0.81±0.06,0.91±0.03和1.42±0.14,Bax蛋白表达水平分别为0.29±0.01,0.75±0.09,0.79±0.12和1.21±0.06。上述指标,TFP组与对照组相比,TFP+si-GPC3组与TFP组相比,差异均有统计学意义(均P<0.05)。结论肝癌细胞增殖、凋亡与GPC3基因沉默联合TFP干预有显著相关性。 Objective To analyze the effect of phosphatidylinositol proteoglycan 3(GPC3)gene silting combined with trifluoperazine(TFP)on the proliferation and apoptosis of liver cancer cells.Methods HepG2 cells were divided into control group,TFP group,TFP+si-NC group and TFP+si-GPC3 group.TFP group was treated with 20μmol·L^(-1) TFP,TFP+si-NC group transfected si-NC and treated with 20μmol·L^(-1) TFP,TFP+si-GPC3 group transfected si-GPC3 and treated with 20μmol·L^(-1) TFP,control group was neither transfected nor treated with TFP.Cell counting kit-8(CCK-8)method was used to detect the inhibition of different concentrations of TFP on the growth of HepG2 cells.The semi-inhibitory concentration(IC50)of TFP was calculated and the optimal concentration was selected.The apoptosis of hepatoma cells were analyzed by flow cytometry.Western blot was used to detect the expression of apoptosis-related proteins Cl-caspase-3,B-cell lymphoma-2-associated X(Bax).Real-time quantitative polymerase chain reaction(qRT-PCR)and Western blotting were used to detect the expression of GPC3 mRNA and GPC3 protein.The cell viability of HepG2 cells was detected by CCK-8 assay.Results The protein expression levels of GPC3 protein in control group,TFP group,TFP+si-NC group and TFP+si-GPC3 group were 0.90±0.06,0.57±0.07,0.57±0.08 and 0.27±0.06,respectively;the cell viability were(100.00±0.00)%,(54.47±5.95)%,(52.24±4.10)%,(22.70±2.86)%,respectively;the apoptosis rates were(2.84±0.61)%,(22.37±1.36)%,(20.82±0.81)%,(31.72±1.92)%,respectively;Cl-caspase-3 protein expression levels were 0.37±0.05,0.81±0.06,0.91±0.03,1.42±0.14,respectively;Bax protein expression levels were 0.29±0.01,0.75±0.09,0.79±0.12,1.21±0.06,respectively.Compared between control group and TFP group,between TFP group and TFP+si-GPC3 group,the differences were statistically significant(all P<0.05).Conclusion The proliferation and apoptosis of hepatoma cells were significantly correlated with GPC3 gene silencing combined with TFP intervention.
作者 马奎 张璁 高超 杨建 MA Kui;ZHANG Cong;GAO Chao;YANG Jian(Hebei Life Origin Bio-Technology Co.Ltd.,Hebei Province Cell and Tissue Cryopreservation Application Engineering Technology Center,Shijiazhuang 050011,Hebei Province,China;Scientific Research Center,The Fourth Hospital of Hebei Medical University,Shijiazhuang 050000,Hebei Province,China)
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2022年第10期1060-1063,共4页 The Chinese Journal of Clinical Pharmacology
关键词 三氟拉嗪 磷脂酰肌醇蛋白多糖3 肝细胞癌 细胞凋亡 trifluoperazine phosphatidylinositol proteoglycan 3 hepatocellular carcinoma cell apoptosis
  • 相关文献

参考文献8

二级参考文献30

  • 1Research Center of Clinical Medicine,Affiliated Hospital of Nantong University,Nantong 226001,China (Yao M,Yao DF,Qiu LW,Wu W,Sai WL,Yang JL and Zhang HJ),Department of Oncology,Yancheng First People’s Hospital,Yancheng 224001,China (Bian YZ),Department of Oncology,Second Affiliated Hospital,Nanjing Medical University,Nanjing 210011,China (Zhang CG).Oncofetal antigen glypican-3 as a promising early diagnostic marker for hepatocellular carcinoma[J].Hepatobiliary & Pancreatic Diseases International,2011,10(3):289-294. 被引量:52
  • 2俞梅,沈铿,杨佳欣,黄惠芳,吴鸣,潘凌亚,郎景和,连利娟.高分化子宫内膜样癌及子宫内膜重度不典型增生患者孕激素治疗的临床分析[J].中华妇产科杂志,2006,41(4):242-245. 被引量:28
  • 3Kyo S, Sakaguchi J, Kiyono T, et al. Forkhead transcription factor FOXO1 is a direct target of progestin to inhibit endometrial epithelial cell growth [ J ]. Clin Cancer Res,2011, 17 (3) : 525 - 537.
  • 4Sangodkar J, Dhawan NS, Melville H, et al. Targeting the FOXOI/ KLF6 axis regulates EGFR signaling and treatment response [ J]. JClin Invest, 2012,122 (7) : 2637 - 2651.
  • 5Kaku T, Yoshikawa H, Tsuda H, et al. Con-servative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endome- trium in young women: central pathologic review and treatment out-come[J]. CancerLett, 2001, 167(1): 39 -48.
  • 6Gotlieb WH, Beiner ME, Shalmon B, et al. Outcome of iertility- sparing treatment with progestins in young patients with endometrial cancer[J]. Obstet Gynecol, 2003, 102(4): 718-725.
  • 7Gunderson CC, Fader AN, Carson KA, et al. Oncologic and repro- ductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review [ J ]. Gynecol Oncol, 2012, 125(2) : 477 -482.
  • 8DiFeo A, Martignetti JA, Narla G. The role of KLF6 and its splice variants in cancer therapy [ J ]. Drug Resist Updat, 2009, 12 (1-2): 1-7.
  • 9Gehran RC, D'Astolfo DS, Prieto C,et al. Genomic organization and functional analysis of the gene encoding the Krtlppel-like transcription factor KLF6[J]. Biochim Biophys Acta, 2005, 1730(2) : 137 - 146.
  • 10Li D,Yea S, Li S, et al. Krtippel-like factor-6 promotes preadipo- cyte differentiation through histone deacetylase 3-dependent repres- sion ofDLKI[J]. JBiolChem,2005, 280(29): 26941 -26952.

共引文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部